Survival rates after liver transplantation have improved steadily because of earlier referral
and timely evaluation, judicious patient selection, improved surgical techniques, superior …

Pegylated interferon with ribavirin (Peg/R) is the most effective therapy for chronic hepatitis
C virus (HCV) but its utility and effectiveness after liver transplantation has been difficult to …

The aim of this study was to determine the influence of donor graft steatosis on overall
outcome, viral recurrence, and fibrosis progression in orthotopic liver transplantation (OLT) …

Background. In hepatitis C virus (HCV)-positive liver transplant recipients, infection of the
allograft and recurrent liver disease are important problems. Increased donor age has …

Hepatitis C virus (HCV) infection is a major health care issue in liver and kidney
transplantation. Besides negatively affecting both patient and graft survival, HCV is …

Cirrhosis due to chronic hepatitis C is the leading indication for liver transplantation in
Europe, United States and Japan. Reinfection after liver transplantation is universal and …

Since the first successful liver transplant by Dr. Thomas Starzl in 1967, the procedure has
become an established treatment for patients with end-stage liver disease (ESLD) of any …

A 52-year-old man had cadaveric liver transplantation (LT) for hepatitis C virus (HCV)-
related cirrhosis in May 2002. HCV recurrence developed with moderate inflammation and …

We evaluated the safety and efficacy of an escalating dose regimen of pegylated interferon α‐
2a (PEG‐IFNα‐2a) and ribavirin in the early phase of recurrent hepatitis C after orthotopic …

There is still little understanding of the immune events that occur in transplant patients as
they develop a relationship with their graft alloantigens. Though, there is an enormous …